Could ambulance asthma treatment keep kids out of the hospital?

NCT ID NCT06074185

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether giving two asthma medications (ipratropium and dexamethasone) to children during ambulance transport can reduce hospital admissions. The study included 44 children aged 2 to 17 with severe wheezing. The goal was to see if this early treatment is feasible and effective in real-world emergency settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ipratropium bromide and dexamethasone
What this could lead to
If successful, this approach could help children with severe asthma attacks get faster relief and avoid hospitalization.
What could go wrong
This is a small pilot study with only 44 participants, so results may not apply broadly. The treatments are already used in hospitals, but their benefit in ambulances is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE WHEEZING DUE TO ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mecklenburg County EMS

    Charlotte, North Carolina, 28208, United States

  • University at Buffalo

    Buffalo, New York, 14261, United States

  • University of Utah

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.